Dow Down 0.02% Nasdaq Down 0.07%

TrovaGene, Inc. (TROV)

-NasdaqCM
1.15 Up 0.15(15.00%) Mar 23, 4:00PM EDT
|After Hours : 1.15 0.00 (0.00%) Mar 23, 5:15PM EDT
Prev Close:1.00
Open:1.05
Bid:N/A
Ask:1.25 x 400
1y Target Est:0.50
Beta:0.573011
Earnings Date:May 8 - May 12 (Est.)
Day's Range:1.00 - 1.15
52wk Range:1.00 - 6.67
Volume:470,125
Avg Vol (3m):318,035
Market Cap:35.61M
P/E (ttm):N/A
EPS (ttm):-1.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):81.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :-1.08
Quarterly EPS Est (Mar-17) :-0.29
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary molecular genetic detection technology for use in pharmaceutical development, clinical research, and medical testing in various clinic... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback